PMID- 33410266 OWN - NLM STAT- MEDLINE DCOM- 20210621 LR - 20210621 IS - 1447-0756 (Electronic) IS - 1341-8076 (Linking) VI - 47 IP - 3 DP - 2021 Mar TI - Effects of androgenic properties of progestin combined with ethinyl estradiol on vascular endothelial reactivity, plasma lipids and free radical production in women with endometriosis. PG - 941-948 LID - 10.1111/jog.14620 [doi] AB - AIM: Endothelial reactivity is inhibited and oxidative stress is enhanced in women with endometriosis. Testosterone may adversely affect lipids and endothelium. We investigated the effects of androgenic properties of progestins combined with ethinyl estradiol (EE) on endothelial function, lipids and free radical production in such women. METHODS: Women with endometriosis were treated with 20 mug EE + 3 mg drospirenone (DRSP) or 35 mug EE + 1 mg norethisterone (NET) for 3 months. Plasma concentrations of sex hormone-binding globulin (SHBG), lipids, copper (Cu), derivatives of reactive oxygen metabolites (d-ROMs), biological antioxidant potential (BAP), nitrite/nitrate, endothelin-1 and asymmetrical dimethylarginine (ADMA) were measured before and after treatment. Flow-mediated vasodilation (FMD) of the brachial artery was measured by ultrasonography. RESULTS: DRSP group, but not NET group, significantly increased FMD and concentrations of nitrite/nitrate and small dense LDL cholesterol, while decreased endothelin-1 concentrations. In both groups, ADMA and LDL cholesterol concentrations were significantly decreased, but triglyceride, SHBG, d-ROMs, Cu and ceruloplasmin concentrations increased, and BAP concentrations did not change. DRSP group significantly increased HDL cholesterol concentrations, whereas NET group decreased its concentrations. Changes in triglyceride correlated positively either with changes in SHBG (r = 0.57, P < 0.001) or with small dense LDL cholesterol (r = 0.45, P = 0.005). Changes in Cu correlated positively with changes in d-ROMs (r = 0.87, P < 0.001). CONCLUSION: Androgenic properties of progestin may counteract EE's favorable effects on endothelial function and HDL cholesterol, while eliminating its adverse effects on increased triglyceride-induced small dense LDL cholesterol in women with endometriosis. CI - (c) 2021 Japan Society of Obstetrics and Gynecology. FAU - Sakurada, Takahiro AU - Sakurada T AD - Department of Obstetrics and Gynecology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan. FAU - Matsushita, Hiroshi AU - Matsushita H AD - Department of Obstetrics and Gynecology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan. FAU - Noguchi, Yasuyuki AU - Noguchi Y AD - Department of Obstetrics and Gynecology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan. FAU - Shinohara, Koichi AU - Shinohara K AD - Department of Obstetrics and Gynecology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan. FAU - Watanabe, Kazushi AU - Watanabe K AD - Department of Obstetrics and Gynecology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan. FAU - Wakatsuki, Akihiko AU - Wakatsuki A AD - Department of Obstetrics and Gynecology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan. LA - eng GR - 17K11302/Japan Society for the Promotion of Science/ PT - Journal Article DEP - 20210106 PL - Australia TA - J Obstet Gynaecol Res JT - The journal of obstetrics and gynaecology research JID - 9612761 RN - 0 (Androgens) RN - 0 (Contraceptives, Oral, Combined) RN - 0 (Free Radicals) RN - 0 (Lipids) RN - 0 (Progestins) RN - 423D2T571U (Ethinyl Estradiol) RN - 97C5T2UQ7J (Cholesterol) SB - IM MH - Androgens MH - Cholesterol MH - Contraceptives, Oral, Combined/adverse effects MH - *Endometriosis/drug therapy MH - Endothelium MH - Ethinyl Estradiol MH - Female MH - Free Radicals MH - Humans MH - Lipids MH - *Progestins OTO - NOTNLM OT - HDL cholesterol OT - endometriosis OT - free radical OT - small dense LDL cholesterol OT - vascular function EDAT- 2021/01/08 06:00 MHDA- 2021/06/22 06:00 CRDT- 2021/01/07 06:17 PHST- 2020/07/29 00:00 [received] PHST- 2020/11/10 00:00 [revised] PHST- 2020/12/10 00:00 [accepted] PHST- 2021/01/08 06:00 [pubmed] PHST- 2021/06/22 06:00 [medline] PHST- 2021/01/07 06:17 [entrez] AID - 10.1111/jog.14620 [doi] PST - ppublish SO - J Obstet Gynaecol Res. 2021 Mar;47(3):941-948. doi: 10.1111/jog.14620. Epub 2021 Jan 6.